Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$966M |
| 2 |
Microsoft
MSFT
|
+$734M |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$643M |
| 4 |
IBM
IBM
|
+$529M |
| 5 |
Philip Morris
PM
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
ExxonMobil
XOM
|
+$971M |
| 3 |
Applied Materials
AMAT
|
+$728M |
| 4 |
Honeywell
HON
|
+$684M |
| 5 |
TSMC
TSM
|
+$562M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.2% |
| 2 | Financials | 11.32% |
| 3 | Healthcare | 9.56% |
| 4 | Industrials | 9.21% |
| 5 | Consumer Discretionary | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
Key Tronic
KTCC
$45.7M
| $94.6K | ﹤0.01% |
22,913
| – | – |
|
4102
OPAL Fuels
OPAL
$78.9M
| $91.6K | ﹤0.01% |
41,636
-103
| -0.2% | -$226 |
|
4103
XBiotech
XBIT
$69.5M
| $90.5K | ﹤0.01% |
39,355
| – | – |
|
4104
Lantern Pharma
LTRN
$35.9M
| $88.8K | ﹤0.01% |
21,301
| – | – |
|
|
TGB
4105
Trekor Metals
TGB
$3.21B
| $88.5K | ﹤0.01% |
+12,859
| New | +$91.9K |
|
4106
Byrna Technologies
BYRN
$110M
| $86.2K | ﹤0.01% |
12,852
-39,827
| -76% | -$245K |
|
|
EXK
4107
Endeavour Silver
EXK
$3.03B
| $84.6K | ﹤0.01% |
+10,219
| New | +$95.1K |
|
|
SBC
4108
SBC Medical Group
SBC
$316M
| $83.1K | ﹤0.01% |
26,991
+16,811
| +165% | +$57K |
|
4109
Beyond Meat
BYND
$268M
| $81.8K | ﹤0.01% |
109,072
-903,916
| -89% | -$702K |
|
|
SCZM
4110
Santacruz Silver Mining Ltd
SCZM
$833M
| $81.1K | ﹤0.01% |
12,501
| – | – |
|
4111
BTCS Inc
BTCS
$56.2M
| $80K | ﹤0.01% |
72,044
-1,602
| -2% | -$2.58K |
|
4112
LifeVantage
LFVN
$84.3M
| $77.6K | ﹤0.01% |
12,436
-21,111
| -63% | -$128K |
|
|
TOYO
4113
TOYO Co
TOYO
$229M
| $77K | ﹤0.01% |
+11,074
| New | +$136K |
|
|
AISP
4114
Airship AI Holdings
AISP
$69.9M
| $76.1K | ﹤0.01% |
31,851
-44,387
| -58% | -$113K |
|
4115
Standard BioTools
LAB
$310M
| $74.3K | ﹤0.01% |
90,282
-676,671
| -88% | -$639K |
|
|
ZENA
4116
ZenaTech Inc
ZENA
$152M
| $69.2K | ﹤0.01% |
+46,133
| New | +$82.7K |
|
|
FINV
4117
FinVolution Group
FINV
$1.11B
| $69.2K | ﹤0.01% |
14,440
+2,580
| +22% | +$12.8K |
|
4118
Denison Mines
DNN
$2.95B
| $68.7K | ﹤0.01% |
22,466
+2,646
| +13% | +$9.22K |
|
4119
Definitive Healthcare
DH
$73.7M
| $67.7K | ﹤0.01% |
81,487
-113,362
| -58% | -$104K |
|
4120
Telomir Pharmaceuticals
TELO
$80.5M
| $65.9K | ﹤0.01% |
51,454
| – | – |
|
4121
Ultralife
ULBI
$116M
| $65.7K | ﹤0.01% |
10,403
| – | – |
|
4122
Harvard Bioscience
HBIO
$28.8M
| $62.9K | ﹤0.01% |
10,230
| – | – |
|
|
DPRO
4123
Draganfly
DPRO
$174M
| $62.4K | ﹤0.01% |
+11,511
| New | +$66.7K |
|
4124
Elicio Therapeutics
ELTX
$81.4M
| $62.1K | ﹤0.01% |
+15,884
| New | +$159K |
|
4125
Inter&Co
INTR
$2.36B
| $61.8K | ﹤0.01% |
11,378
-12,593
| -53% | -$84.6K |
|
Similar funds
Bank of New York Mellon's Q2 2026 Portfolio in Review
As of Q2 2026, Bank of New York Mellon held 4,477 positions worth $609B, up 12% from $544B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q2 2026 filing shows 283 new, 2,266 increased, 1,637 reduced and 188 closed positions. Its largest new stake was Honeywell Aerospace: 2,914,841 shares worth $644M. The largest sale was Apple, an estimated $1.07B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q2 2026 buy was Honeywell Aerospace: 2,914,841 shares worth $644M.
- Bank of New York Mellon added most to Marvell Technology in Q2 2026, an estimated $966M increase.
- Bank of New York Mellon's biggest Q2 2026 reduction was Apple, cutting an estimated $1.07B.
- Bank of New York Mellon fully exited Coterra Energy in Q2 2026, selling an estimated $298M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $609B portfolio in Q2 2026.
- Bank of New York Mellon opened 283 new positions and closed 188 in Q2 2026.
- Bank of New York Mellon's portfolio value rose 12% quarter-over-quarter to $609B.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.